A patient with concurrent prurigo nodularis and squamous cell carcinomas of keratoacanthoma type: The role of aprepitant in diagnostic clarity [PDF]
, 2019 Patrick Jedlowski +3 more
openalex +1 more source
P35 Aprepitant in the prevention of cardiotoxic adverse effects of Doxorubicin in the paediatric population – a systematic literature investigation [PDF]
, 2019 Martin Feickert, BB Burckhardt
openalex +1 more source
The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant [PDF]
, 2023 Rafael Coveñas +3 more
openalex +1 more source
A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) [PDF]
, 2017 L. Zhang +9 more
openalex +1 more source
Journal of Research in Medical Sciences, 2015 Background: Depending on the site of irradiation, about 40-80% of patients undergoing radiotherapy (RT) will experience nausea and/or vomiting. The current study aimed to investigate the efficacy of ondansetronas as a single agent and with a combination ...
Hamid Emami +6 more
doaj
Aprepitant for gefitinib-induced refractory pruritus in Chinese malignancy population [PDF]
, 2019 Haifeng Qin +9 more
openalex +1 more source
Clinical Pharmacology: Advances and Applications, 2019 Anuradha Kanaparthi,1 Sarah Kukura,2 Natalie Slenkovich,2 Faris AlGhamdi,2 Shabana Z Shafy,2 Mohammed Hakim,2 Joseph D Tobias2,3 1College of Medicine, Northeast Ohio Medical University (NEOMED), Rootstown, Ohio, USA; 2Department of Anesthesiology & ...
Kanaparthi A +6 more
doaj
Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types [PDF]
, 2017 Jeong Eun Kim +13 more
openalex +1 more source